Legis Daily

A bill to establish or continue a multidisciplinary research program to advance the discovery and preclinical development of medical products for priority virus families and other viral pathogens with a significant potential to cause a pandemic, and for other purposes.

USA117th CongressS-3489| Senate 
| Updated: 1/12/2022
Richard Burr

Richard Burr

Republican Senator

North Carolina

Cosponsors (1)
John W. Hickenlooper (Democratic)

Health, Education, Labor, and Pensions Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
This bill directs the National Institutes of Health (NIH) to support research on medical products for virus families and viral pathogens with pandemic potential. Specifically, the NIH must establish or continue a multidisciplinary program for supporting research centers to advance the discovery and development of medical products to prevent, treat, and diagnose such viruses.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Jan 12, 2022
Introduced in Senate
Jan 12, 2022
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
  • January 12, 2022
    Introduced in Senate


  • January 12, 2022
    Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Health

Chemical and biological weaponsDepartment of Health and Human ServicesDrug therapyEmergency medical services and trauma careHazardous wastes and toxic substancesHealth programs administration and fundingHealth promotion and preventive careHealth technology, devices, suppliesHome and outpatient careInfectious and parasitic diseasesMedical researchMedical tests and diagnostic methodsNational Institutes of Health (NIH)Nuclear weaponsProduct development and innovationResearch administration and fundingResearch and developmentScientific communication

A bill to establish or continue a multidisciplinary research program to advance the discovery and preclinical development of medical products for priority virus families and other viral pathogens with a significant potential to cause a pandemic, and for other purposes.

USA117th CongressS-3489| Senate 
| Updated: 1/12/2022
This bill directs the National Institutes of Health (NIH) to support research on medical products for virus families and viral pathogens with pandemic potential. Specifically, the NIH must establish or continue a multidisciplinary program for supporting research centers to advance the discovery and development of medical products to prevent, treat, and diagnose such viruses.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Jan 12, 2022
Introduced in Senate
Jan 12, 2022
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
  • January 12, 2022
    Introduced in Senate


  • January 12, 2022
    Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Richard Burr

Richard Burr

Republican Senator

North Carolina

Cosponsors (1)
John W. Hickenlooper (Democratic)

Health, Education, Labor, and Pensions Committee

Health

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Chemical and biological weaponsDepartment of Health and Human ServicesDrug therapyEmergency medical services and trauma careHazardous wastes and toxic substancesHealth programs administration and fundingHealth promotion and preventive careHealth technology, devices, suppliesHome and outpatient careInfectious and parasitic diseasesMedical researchMedical tests and diagnostic methodsNational Institutes of Health (NIH)Nuclear weaponsProduct development and innovationResearch administration and fundingResearch and developmentScientific communication